Literature DB >> 1686066

Approaches to the design of biochemical probes for positron emission tomography.

J R Barrio1.   

Abstract

Since the development of the 2-deoxy-D-glucose procedure by L. Sokoloff considerable advances have been made in the design of radiotracers for estimation of in-vivo biochemical parameters. Many of these advances are due to the development of positron emission tomography. As a result key biochemical processes can now be evaluated with newly developed positron-emitting labeled enzyme probes in man, in-vivo, allowing the study of a wide range of specific cellular processes in health and disease states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686066     DOI: 10.1007/bf00965849

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  50 in total

1.  Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

Authors:  J S Fowler; R R MacGregor; A P Wolf; C D Arnett; S L Dewey; D Schlyer; D Christman; J Logan; M Smith; H Sachs
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 2.  Fluorinated substrate analogs: routes of metabolism and selective toxicity.

Authors:  C Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1983

3.  Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.

Authors:  C D Arnett; J S Fowler; R R MacGregor; D J Schlyer; A P Wolf; B Långström; C Halldin
Journal:  J Neurochem       Date:  1987-08       Impact factor: 5.372

4.  Evidence that catecholamine transport into chromaffin vesicles is coupled to vesicle membrane potential.

Authors:  R W Holz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.

Authors:  M M Bahn; S C Huang; R A Hawkins; N Satyamurthy; J M Hoffman; J R Barrio; J C Mazziotta; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1989-12       Impact factor: 6.200

6.  6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

Authors:  J R Barrio; S C Huang; W P Melega; D C Yu; J M Hoffman; J S Schneider; N Satyamurthy; J C Mazziotta; M E Phelps
Journal:  J Neurosci Res       Date:  1990-12       Impact factor: 4.164

7.  A fluorescent modification of adenosine triphosphate with activity in enzyme systems: 1,N 6 -ethenoadenosine triphosphate.

Authors:  J A Secrist; J R Barrio; N J Leonard
Journal:  Science       Date:  1972-02-11       Impact factor: 47.728

8.  Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography.

Authors:  E S Garnett; C Nahmias; G Firnau
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

9.  6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.

Authors:  W P Melega; J M Hoffman; J S Schneider; M E Phelps; J R Barrio
Journal:  Brain Res       Date:  1991-03-15       Impact factor: 3.252

10.  Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.

Authors:  K L Leenders; S M Aquilonius; K Bergström; P Bjurling; A R Crossman; S A Eckernas; A G Gee; P Hartvig; H Lundqvist; B Långström
Journal:  Brain Res       Date:  1988-03-29       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.